Zhejiang Taimei Medical Technology Future Growth
Future criteria checks 1/6
Zhejiang Taimei Medical Technology is forecast to grow revenue at 13.6% per annum.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
| Life Sciences earnings growth | 44.8% |
| Revenue growth rate | 13.6% |
| Future return on equity | 2.0% |
| Analyst coverage | Low |
| Last updated | 14 Nov 2024 |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 811 | N/A | N/A | N/A | 1 |
| 12/31/2025 | 687 | N/A | N/A | N/A | 1 |
| 12/31/2024 | 573 | N/A | N/A | N/A | 1 |
| 3/31/2024 | 576 | -359 | -312 | -305 | N/A |
| 12/31/2023 | 573 | -347 | -361 | -351 | N/A |
| 12/31/2022 | 549 | -413 | -357 | -329 | N/A |
| 12/31/2021 | 466 | -480 | -250 | -218 | N/A |
| 12/31/2020 | 303 | -524 | -110 | -102 | N/A |
| 12/31/2019 | 187 | -389 | -131 | -126 | N/A |
| 12/31/2018 | 60 | -183 | -64 | -61 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if 2576's forecast earnings growth is above the savings rate (2.3%).
Earnings vs Market: Insufficient data to determine if 2576's earnings are forecast to grow faster than the Hong Kong market
High Growth Earnings: Insufficient data to determine if 2576's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: 2576's revenue (13.6% per year) is forecast to grow faster than the Hong Kong market (7.7% per year).
High Growth Revenue: 2576's revenue (13.6% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 2576's Return on Equity is forecast to be low in 3 years time (2%).